Clinical Trial Update: Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing head and neck cancer radiation with or without amifostine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis
• Stomatitis

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Oral Mucositis, Stomatitis | Phase 4 | Status: WITHDRAWN